Stay updated on China CKD Study of FG-4592 Clinical Trial
Sign up to get notified when there's something new on the China CKD Study of FG-4592 Clinical Trial page.

Latest updates to the China CKD Study of FG-4592 Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed. No study content or page functionality appears to be affected.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.4.2; removed notices about funding lapse and NIH Clinical Center operating status (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check45 days agoChange DetectedA government funding lapse notice with operating status information was added, and the site version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check52 days agoChange DetectedThe page adds a glossary toggle and updates QC-related metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', while the revision label changes to 'Revision: v3.4.0', replacing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange Detected- Sponsor changed from FibroGen to Kyntra Bio. - The Responsible Party field now lists Kyntra Bio as sponsor.SummaryDifference0.2%

Stay in the know with updates to China CKD Study of FG-4592 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the China CKD Study of FG-4592 Clinical Trial page.